Tissue targeted antigenic activation of the immune response to treat cancers
US9775896B2 · kind B2 · utility
3Cited by
10References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 15, 2015 |
| Grant date | Oct 3, 2017 |
| Priority date | — |
| Expiry date | Jul 15, 2035 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides in part methods of treating cancers of a specific organ or tissue by administering a composition that is antigenically specific for one or more microbes that are pathogenic in the specific organ or tissue in which the cancer is situated.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.